Company / R&D Expense
BioNexus Gene Lab Corp R&D Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$50.7K
FY2025
5-year range
$47.5K / $55.0K
FY2023-FY2025
Trend
+6.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $54,982 to $50,670 over the past 2 years.
Based on SEC 10-K filings.
$50,670 in FY2025.
Declined from $54,982 to $50,670 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d expense increased 6.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $50.7K | +6.6% |
| FY2024 | $47.5K | -13.6% |
| FY2023 | $55.0K | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026